Inventor
DORE MICHAEL
US13 patents
⚠️ This page may combine multiple inventors who share the name “DORE MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
8 patentsUS10968235B2Apr 6, 2021
N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
NOVARTIS AG3 citations83
US10336774B2Jul 2, 2019
N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
NOVARTIS AG7 citations83
US10301278B2May 28, 2019
1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2
NOVARTIS AG8 citations83
US10975080B2Apr 13, 2021
Compounds and compositions for inhibiting the activity of SHP2
NOVARTIS AG2 citations70
US12209098B2Jan 28, 2025
N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
NOVARTIS AG0 citations62
US11952386B2Apr 9, 2024
N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
NOVARTIS AG0 citations62
US12544374B2Feb 10, 2026
AZA-quinoline compounds and uses thereof
NOVARTIS AG0 citations47
US12473273B2Nov 18, 2025
Quinoline compounds and compositions for inhibiting EZH2
NOVARTIS AG0 citations47
UNIV MONTREAL
3 patentsUS12139488B2Nov 12, 2024
Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease
UNIV MONTREAL2 citations72
US12060353B2Aug 13, 2024
Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease
UNIV MONTREAL3 citations69
US12479842B2Nov 25, 2025
Pyrido[3,2-d]pyrimidine compounds uses thereof for treating a proliferative disease
UNIV MONTREAL0 citations58